Basics |
Company: |
Seelos Therapeutics, Inc. |
IPO Date: |
May 1, 1999 |
Sector: |
Healthcare |
Industry: |
Pharma |
Activated in VL: |
False |
Average Daily Range |
Avg Daily Range: |
$0.08 | 5.22%
|
Avg Daily Range (30 D): |
$0.11 | 22.00%
|
Avg Daily Range (90 D): |
$0.09 | 7.51%
|
Institutional Daily Volume |
Avg Daily Volume: |
.02M |
Avg Daily Volume (30 D): |
M |
Avg Daily Volume (90 D): |
.27M |
Trade Size |
Avg Trade Size (Sh.): |
3 |
Avg Trade Size (Sh.) (30 D): |
288 |
Avg Trade Size (Sh.) (90 D): |
44 |
Institutional Trades |
Total Inst.Trades: |
48 |
Avg Inst. Trade: |
$2.45M |
Avg Inst. Trade (30 D): |
$6.21M |
Avg Inst. Trade (90 D): |
$6.21M |
Avg Inst. Trade Volume: |
M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$4.25M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
.47K |
|
|
|
|
Financials |
|
TTM |
Q1 2024 |
Q4 2023 |
Basic EPS
|
$.68
|
$-.2
|
$-7.47
|
Diluted EPS
|
$.12
|
$-.2
|
$-7.47
|
Revenue
|
$ .38M
|
$ .58M
|
$ .65M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 1.71M
|
$ -2.66M
|
$ -5.45M
|
Operating Income / Loss
|
$ -3.14M
|
$ -6.06M
|
$ -8.01M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ M
|
$ M
|
$ M
|
PE Ratio
|
0.00
|
|
|
|